Well Lead Medical Co., Ltd. (603309.SS)

12.82 +0.10 (+0.79%) At close: 03:00PM CST

Well Lead Medical Co., Ltd.

47 Guomao Avenue South
Panyu
Guangzhou 511434
China
86 20 8475 8878
https://www.wellead.com

Sector(s): Healthcare
Industry: Medical Instruments & Supplies
Full-time employees: 2,622

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Guangyuan Han	Vice Chairman & GM	N/A	N/A	1964
Ms. Yimin Zhu	Chief Financial Officer	N/A	N/A	1980
Ms. Yungui Chen	Deputy GM & Director	N/A	N/A	1975
Mr. Bin Chen	Board Secretary	N/A	N/A	1980

Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CNY.

Description

Well Lead Medical Co., Ltd. engages in the development, production, and sale of medical devices in anaesthesia, urology, endourology, respiratory, pain management, and hemodialysis areas worldwide. It manufactures and sells urology products, including Foley catheter, Nelaton catheters, urine collection products, and accessories; endourology products, such as the ClearPetra family system, ureterorenoscope, guide wires, ureteral stent, and stone retrieval basket; anesthesia products, comprising endotracheal tubes, intubation accessories, laryngeal masks, endobronchial tubes, tracheostomy tubes, anesthesia breathing circuits and accessories, and nasopharyngeal and oropharyngeal airway products; respiratory products, including oxygen and aerosol therapy products, and capnography mask and cannula products; drainage/suction/gastroenterology products, such as drainage systems, Yankauer handles, suction catheters, and stomach and feeding tubes; hemodialysis blood tubing set; home care products, including male external catheter and Convicath intermittent catheter; and ambulatory infusion pump for pain management. The company was founded in 1998 and is headquartered in Guangzhou, China.

Corporate governance

Well Lead Medical Co., Ltd.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.